Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
Addex Therapeutics announced promising preclinical data for its GABAB positive allosteric modulator (PAM) candidate, showing significant anti-tussive ...